DNA Script Inc.
Cambridge, MA Part of DNA Script
- UEI
- V5JNJ33ZCSM3
- CAGE
- 9HVG1
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
DNA Script
Parent
KTGQARYH18T6
- DNA Script Inc. V5JNJ33ZCSM3
-
DNA Script
Parent
KTGQARYH18T6
- SAM.gov registration date
- Physical address
- 185 Alewife Brook Pkwy #210, Cambridge, MA 02138, USA
- Website
- dnascript.com
- Founded
- 2014
- Employees
- 251-1K
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| The purchase of this acquisition is to purchase one (1) syntax system model 200 instrument model STX-200 | National Institute of Allergy and Infectious Diseases | $342,026 | |
| Console software and laptop bundle | Office of Naval Research | $247,955 | |
| Deoxyribonucleic acid synthesizer | Defense Health Agency | $344,505 | |
| Syntax kits | Marketing and Regulatory Programs Business Services | $79,695 | |
| To acquire an oligo synthesizer to generate primers for real-time and conventional PCR assays in-house at the ncah.… | Marketing and Regulatory Programs Business Services | $314,160 |
About DNA Script Inc.
DNA Script Inc. is a foreign-owned, for-profit corporate entity based in Daly City, California, specializing in advanced DNA synthesis technologies and associated products and services. The company develops innovative genetic research tools, particularly focusing on enzyme-based DNA synthesizer systems that offer unique technological advantages over traditional synthesis methods. Registered in the System for Award Management (SAM) with an active registration until July 14, 2025, DNA Script provides cutting-edge genetic research equipment to various U.S. federal government agencies.
Over the past year, DNA Script Inc. has secured multiple prime federal contract awards totaling approximately $1,088,341.60 from agencies including the National Institute of Allergy and Infectious Diseases (NIAID), Office of Naval Research (ONR), Defense Health Agency, and the USDA Animal and Plant Health Inspection Service Veterinary Services. These contracts primarily involve the procurement of Syntax System DNA synthesizers, associated software, and genetic research kits, with most awards being firm fixed-price purchase orders. The company's specialized equipment has been utilized for critical research applications such as vaccine production, pathogen discovery, disease monitoring, and genetic analysis. The contracts have ranged from providing oligo synthesizers for generating polymerase chain reaction assays to supplying DNA synthesis instruments for research and development activities. One contract was set aside for small businesses, while the others had no specific set-aside designation, indicating DNA Script's ability to compete effectively across different federal procurement contexts.
Quick answers
What is DNA Script Inc.'s UEI?
DNA Script Inc.'s Unique Entity ID (UEI) in SAM.gov is V5JNJ33ZCSM3.
What is DNA Script Inc.'s CAGE code?
DNA Script Inc.'s CAGE code is 9HVG1.
What is DNA Script Inc.'s primary NAICS code?
DNA Script Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is DNA Script Inc. located?
DNA Script Inc.'s physical address in SAM.gov is 185 Alewife Brook Pkwy #210, Cambridge, MA 02138, USA.
Is DNA Script Inc. registered in SAM.gov?
Yes. DNA Script Inc.'s SAM.gov registration is active through June 30, 2027.
Who is DNA Script Inc.'s parent company?
DNA Script Inc. is part of DNA Script.
What is DNA Script Inc.'s most recent federal award?
DNA Script Inc.'s most recent federal contract award is The purchase of this acquisition is to purchase one (1) syntax system model 200 instrument model STX-200 (75N93024P01215), from National Institute of Allergy and Infectious Diseases, on September 26, 2024.
On GovTribe
See DNA Script Inc.'s full federal record
- Federal contract awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors